
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 1,161 | 60.1% | -0.06 | 1,111 | 60.7% |
| AL(R) | 750 | 38.8% | -0.07 | 715 | 39.0% |
| CentralBrain-unspecified | 21 | 1.1% | -2.07 | 5 | 0.3% |
| upstream partner | # | NT | conns ORN_VA1d | % In | CV |
|---|---|---|---|---|---|
| ORN_VA1d | 117 | ACh | 17.1 | 27.7% | 0.7 |
| lLN2F_b (L) | 2 | GABA | 3.6 | 5.8% | 0.1 |
| lLN2F_b (R) | 2 | GABA | 3.5 | 5.6% | 0.7 |
| lLN2P_b (L) | 4 | GABA | 3.2 | 5.2% | 0.2 |
| lLN2P_b (R) | 6 | GABA | 2.6 | 4.2% | 0.7 |
| ALIN5 (R) | 1 | GABA | 2.4 | 3.9% | 0.0 |
| lLN2F_a (R) | 2 | unc | 2.4 | 3.9% | 0.3 |
| lLN2T_b (R) | 2 | ACh | 2.2 | 3.5% | 0.4 |
| il3LN6 (R) | 1 | GABA | 2.2 | 3.5% | 0.0 |
| lLN9 (R) | 4 | GABA | 2.0 | 3.3% | 0.5 |
| lLN2T_b (L) | 2 | ACh | 2 | 3.2% | 0.2 |
| lLN2T_e (L) | 2 | ACh | 2.0 | 3.2% | 0.3 |
| lLN2T_d (L) | 2 | unc | 1.9 | 3.0% | 0.2 |
| lLN2F_a (L) | 2 | unc | 1.9 | 3.0% | 0.1 |
| il3LN6 (L) | 1 | GABA | 1.5 | 2.5% | 0.0 |
| lLN9 (L) | 2 | GABA | 1.4 | 2.3% | 0.7 |
| ALIN5 (L) | 1 | GABA | 1.1 | 1.8% | 0.0 |
| lLN2T_d (R) | 2 | unc | 1.0 | 1.5% | 0.1 |
| ORN_VA1v | 14 | ACh | 0.8 | 1.3% | 0.5 |
| v2LN36 (L) | 1 | Glu | 0.7 | 1.1% | 0.0 |
| lLN2T_c (L) | 2 | ACh | 0.7 | 1.1% | 0.5 |
| lLN2T_c (R) | 2 | ACh | 0.6 | 0.9% | 0.8 |
| lLN2X04 (L) | 2 | ACh | 0.5 | 0.8% | 0.7 |
| ORN_DA4m | 6 | ACh | 0.5 | 0.8% | 0.5 |
| v2LN36 (R) | 1 | Glu | 0.5 | 0.8% | 0.0 |
| lLN2T_e (R) | 1 | ACh | 0.4 | 0.7% | 0.0 |
| VA1d_adPN (L) | 3 | ACh | 0.4 | 0.6% | 0.7 |
| lLN1_bc (L) | 8 | ACh | 0.4 | 0.6% | 0.3 |
| VA1d_adPN (R) | 3 | ACh | 0.3 | 0.4% | 0.4 |
| lLN2X04 (R) | 2 | ACh | 0.2 | 0.4% | 0.6 |
| lLN1_bc (R) | 4 | ACh | 0.2 | 0.4% | 0.3 |
| v2LN30 (L) | 1 | unc | 0.2 | 0.4% | 0.0 |
| ORN_DC3 | 3 | ACh | 0.2 | 0.3% | 0.4 |
| ORN_DA1 | 1 | ACh | 0.1 | 0.2% | 0.0 |
| lLN2X12 (L) | 2 | ACh | 0.1 | 0.2% | 0.3 |
| AL-AST1 (L) | 1 | ACh | 0.1 | 0.2% | 0.0 |
| lLN2T_a (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| lLN2P_c (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| lLN2X12 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DA4l | 2 | ACh | 0.1 | 0.1% | 0.0 |
| ALIN7 (L) | 1 | GABA | 0.0 | 0.1% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 0.0 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.0 | 0.1% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.0 | 0.1% | 0.0 |
| v2LN3A1_b (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| v2LN34D (R) | 1 | Glu | 0.0 | 0.1% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| v2LN30 (R) | 1 | unc | 0.0 | 0.1% | 0.0 |
| ORN_DA2 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ALIN7 (R) | 1 | GABA | 0.0 | 0.1% | 0.0 |
| AL-MBDL1 (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DA3 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| v2LN3A (R) | 1 | unc | 0.0 | 0.1% | 0.0 |
| ORN_VA6 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| downstream partner | # | NT | conns ORN_VA1d | % Out | CV |
|---|---|---|---|---|---|
| VA1d_adPN (L) | 3 | ACh | 39.3 | 17.0% | 0.2 |
| VA1d_adPN (R) | 3 | ACh | 28.6 | 12.3% | 0.2 |
| ORN_VA1d | 115 | ACh | 18.9 | 8.1% | 0.8 |
| MZ_lv2PN (L) | 1 | GABA | 12.3 | 5.3% | 0.0 |
| il3LN6 (L) | 1 | GABA | 11.5 | 5.0% | 0.0 |
| lLN2T_b (R) | 2 | ACh | 10.7 | 4.6% | 0.2 |
| il3LN6 (R) | 1 | GABA | 10.3 | 4.4% | 0.0 |
| M_vPNml63 (L) | 3 | GABA | 8.8 | 3.8% | 0.6 |
| lLN2F_b (R) | 2 | GABA | 8.2 | 3.5% | 0.4 |
| lLN2F_a (R) | 2 | unc | 6.5 | 2.8% | 0.1 |
| lLN2T_c (R) | 2 | ACh | 5.7 | 2.4% | 0.2 |
| lLN2P_b (R) | 6 | GABA | 5.7 | 2.4% | 0.5 |
| v2LN36 (L) | 1 | Glu | 5.4 | 2.3% | 0.0 |
| ALIN7 (L) | 1 | GABA | 5.2 | 2.2% | 0.0 |
| lLN2P_a (R) | 2 | GABA | 5.1 | 2.2% | 0.5 |
| VA1d_vPN (L) | 1 | GABA | 5 | 2.2% | 0.0 |
| v2LN30 (R) | 1 | unc | 2.9 | 1.3% | 0.0 |
| v2LN36 (R) | 1 | Glu | 2.9 | 1.3% | 0.0 |
| lLN2T_b (L) | 2 | ACh | 2.9 | 1.2% | 0.3 |
| lLN2P_b (L) | 4 | GABA | 2.7 | 1.2% | 0.2 |
| lLN2F_b (L) | 2 | GABA | 2.5 | 1.1% | 0.2 |
| M_vPNml63 (R) | 4 | GABA | 2.4 | 1.0% | 0.8 |
| v2LN30 (L) | 1 | unc | 1.9 | 0.8% | 0.0 |
| lLN2P_a (L) | 2 | GABA | 1.7 | 0.8% | 0.1 |
| DA4m_adPN (L) | 1 | ACh | 1.4 | 0.6% | 0.0 |
| MZ_lv2PN (R) | 1 | GABA | 1.4 | 0.6% | 0.0 |
| lLN2F_a (L) | 2 | unc | 1.4 | 0.6% | 0.1 |
| lLN2T_c (L) | 2 | ACh | 1.2 | 0.5% | 0.1 |
| lLN2X04 (R) | 2 | ACh | 1.2 | 0.5% | 0.4 |
| VA1d_vPN (R) | 1 | GABA | 1.0 | 0.5% | 0.0 |
| lLN2T_e (L) | 2 | ACh | 1 | 0.4% | 0.6 |
| lLN9 (R) | 4 | GABA | 1.0 | 0.4% | 0.5 |
| v2LN3A (R) | 2 | unc | 0.9 | 0.4% | 0.7 |
| lLN2P_c (R) | 2 | GABA | 0.9 | 0.4% | 0.5 |
| ORN_DA4m | 10 | ACh | 0.9 | 0.4% | 0.5 |
| ALIN7 (R) | 1 | GABA | 0.8 | 0.4% | 0.0 |
| lLN2T_a (R) | 1 | ACh | 0.8 | 0.4% | 0.0 |
| lLN2P_c (L) | 4 | GABA | 0.8 | 0.3% | 0.9 |
| lLN2X12 (R) | 1 | ACh | 0.7 | 0.3% | 0.0 |
| lLN2T_d (R) | 2 | unc | 0.7 | 0.3% | 0.1 |
| ORN_VA1v | 15 | ACh | 0.7 | 0.3% | 0.3 |
| lLN2T_a (L) | 3 | ACh | 0.7 | 0.3% | 0.4 |
| lLN2T_d (L) | 2 | unc | 0.7 | 0.3% | 0.1 |
| lLN2X04 (L) | 2 | ACh | 0.5 | 0.2% | 0.3 |
| lLN1_bc (R) | 5 | ACh | 0.5 | 0.2% | 0.6 |
| lLN9 (L) | 2 | GABA | 0.4 | 0.2% | 0.2 |
| v2LN34D (L) | 2 | Glu | 0.4 | 0.2% | 0.8 |
| lLN1_bc (L) | 6 | ACh | 0.4 | 0.2% | 0.7 |
| v2LN34A (R) | 3 | Glu | 0.3 | 0.1% | 0.5 |
| v2LN34A (L) | 3 | Glu | 0.3 | 0.1% | 0.4 |
| ALIN5 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| lLN2X05 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| v2LN34D (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| ALON3 (L) | 2 | Glu | 0.2 | 0.1% | 0.5 |
| lLN2T_e (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.1 | 0.1% | 0.0 |
| ALON3 (R) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| M_l2PNm16 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| lLN14 (L) | 2 | GABA | 0.1 | 0.1% | 0.3 |
| M_l2PNl20 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN50 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| M_lvPNm24 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ALIN4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN2X02 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| M_vPNml53 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| CB3679 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| lLN2X05 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| M_vPNml65 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| ALIN5 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN2X12 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN3A (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| v2LN3A1_b (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| AL-MBDL1 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CB3417 (R) | 1 | unc | 0.0 | 0.0% | 0.0 |
| M_l2PNl21 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| v2LN50 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| VA1v_adPN (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_lvPNm40 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| ORN_DC3 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| v2LN34E (L) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| ORN_DA2 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DA4l | 1 | ACh | 0.0 | 0.0% | 0.0 |